AJU IB Investment Co., Ltd.
CIK 1710065 · View on SEC EDGAR ↗
- Portfolio value
- $30.5M
- Positions
- 6
- As of
- March 31, 2026 Data as of Q1 2026
#8,848 of 9,443 by 13F value · top 93.7%
Portfolio value QoQ: +33.9% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 6
- Effective number of positions
- 1.4
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q1 2026: 3.18% Est. buys $1,247,291 · sells $848,729
Median holding: 5.0 quarters Tracked Q4 2024–Q1 2026 · 60.0% still held
- New positions
- 2
- Increased
- 0
- Decreased
- 0
- Closed
- 2
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Sector breakdown
Healthcare
98.7%
Other/Unmapped
1.3%
Full portfolio 6 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| ACLX Arcellx, Inc. - Common Stock | $25,660,663 | 84.07% | 223,486 | $11,089,376 | |||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $1,636,482 | 5.36% | 19,648 | $107,671 | |||
| SEER Seer, Inc. - Class A Common Stock | $1,542,949 | 5.05% | 816,375 | $48,983 | |||
| RLYB Rallybio Corporation - Common Stock | $846,176 | 2.77% | 94,334 | Up ×1 | |||
| STRO Sutro Biopharma, Inc. - Common Stock | $435,925 | 1.43% | 17,500 | $233,450 | |||
| Unknown issuer (CUSIP: 98422T209) | $401,115 | 1.31% | 47,695 | Up ×1 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| RLYB | $846,176 | 94,334 | 2.77% |
| Unknown issuer (CUSIP: 98422T209) | $401,115 | 47,695 | 1.31% |
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| XLO | March 31, 2026 | 667,742 | $427,488 | 8.5% |
| RAPT | March 31, 2026 | 12,437 | $421,241 | No longer tracked |
| CARM | Sept. 30, 2025 | 718,332 | $281,299 | No longer tracked |